Explore our export-ready clinical portfolio engineered across two self-owned smart production complexes in Guangzhou.
Addressing compromised barrier integrity, severe atopy, and contact hypersensitivity through neuro-sensory modulation and biomimetic lamellar lipid restoration.
Dermatologist-formulated and allergist-tested face creams diverge fundamentally from standard cosmetic moisturizers. By integrating targeted bio-fermented peptides such as Acetyl Tetrapeptide-15 and 4-t-butylcyclohexanol, our ODM formulations actively downregulate TRPV1 receptor activation.
This neuro-sensory interception significantly attenuates cutaneous hyper-reactivity, eliminating stinging, burning, and pruritus sensations without requiring corticosteroid compounds.
True barrier recovery requires a precise physiological ratio of Ceramides NP/AP/EOP, Phytosphingosine, and Free Fatty Acids (3:1:1). Our cold-process vacuum homogenization allows the reconstruction of human intercellular lamellar sheets.
Clinical evaporimeter tests demonstrate up to a 68% reduction in Transepidermal Water Loss (TEWL) within 48 hours of topical post-treatment application.
Addressing Type IV delayed-type hypersensitivity requires discarding conventional parabens, MIT/CMIT, phenoxyethanol, and synthetic fragrances. Our laboratories engineer self-preserving matrix solutions utilizing 1,2-Hexanediol, Caprylyl Glycol, and Glyceryl Caprylate.
These polyol antimicrobials simultaneously double as non-irritating humectants, verified through 50-subject Human Repeat Insult Patch Tests (HRIPT).
Unmatched economies of scale, hyper-responsive supply chain integration, and precision cleanroom engineering at Guangzhou Beaza Biotechnology Co., Ltd.
Unlike trading brokers, Beaza directly manages two manufacturing flagships: Guangzhou Aoyan Cosmetics Co., Ltd. and Guangzhou Xinzimei Cosmetics Co., Ltd. Operating over 20 automated micro-emulsification and sterile filling lines under Class 100,000 cleanroom controls ensures absolute batch traceability.
Our formulation capabilities thrive on strategic technical alliances with global raw material innovators including BASF, Symrise, Ashland, and Croda. We synthesize advanced dermatological research directly into shelf-stable, commercially viable private label formulations in our Huadu District R&D centers.
Guangzhou’s integrated supply cluster gives private label buyers immediate access to medical-grade airless syringe dispensers, sterile aluminum-barrier tubes, and high-purity mono-dose ampoules at factory-direct pricing, reducing your initial CAPEX and accelerating time-to-market by 40%.
Consumer demand is moving rapidly away from general hydration toward sterile formulations, post-procedure recovery, and microbiome protection.
With non-invasive aesthetic treatments (fractional laser, chemical peeling, microneedling) surging worldwide, patients face transient, acute barrier ablation. The demand for non-comedogenic, post-procedure allergist face creams designed to accelerate re-epithelialization has grown by 24.6% annually.
Modern allergists avoid sterilizing the skin surface. Contemporary barrier creams incorporate pre- and post-biotic ferments (Lactobacillus, Ectoin, Bifida Ferment Lysate) that competitively inhibit opportunistic pathogen colonization, specifically targeting Staphylococcus aureus flare-ups common in atopic dermatitis.
Top-tier dermocosmetic brands are demanding Ultra-High Temperature (UHT) continuous sterilization during the filling phase, accompanied by hermetic multi-layer pouch-in-bottle or mechanical airless dispenser systems that prevent ambient air backflow, maintaining complete sterility without systemic biocides.
Customizing private label viscosity, occlusion index, and penetration kinetics according to demographic and geographic micro-climates.
Designed for Northern European and North American winter cycles where ambient humidity dips below 20%. Formulated with medical-grade Squalane, Shea butter unsaponifiables, and microcrystalline ceramide webs, creating a durable semi-occlusive mantle preventing moisture sublimation without congesting pores.
Optimized for Southeast Asian and Middle Eastern metropolitan environments. Features ultra-fluid gel-cream textures powered by high molecular weight sodium hyaluronate and Centella Asiatica titrated triterpenes (Madecassoside). Delivers immediate erythema relief without greasy residue in sweltering conditions.
Engineered as a baseline co-prescription moisturizer during prescription retinoid (isotretinoin) therapy, benzoyl peroxide acne regimens, or following ablative CO2 resurfacing. Non-stinging, zero-scent, and physiologically inert to soothe acute peeling and drug-induced cutaneous dermatitis.
Eliminate shipping delays with pre-assembled clinical regulatory documentation tailored to destination authorities worldwide.
Beaza's toxicological safety specialists draft the full Product Information File (PIF) alongside comprehensive Cosmetic Product Safety Reports (CPSR Part A & B) signed by European Safety Assessors, supporting complete notification on the EU CPNP portal.
Our production facilities maintain active FDA registration. We furnish complete facility listing details, cosmetic product listing filings, validated stability profiles, and verified preservative efficacy testing (USP 51) to satisfy all updated MoCRA compliance mandates.
Facilitating seamless customs clearance via Saudi FDA (FASAH/SASO) conformity certification, Certificate of Free Sale (CFS), Halal certification compliance, Certificate of Origin (CO), and thorough safety data documentation (MSDS, batch COA).
A structured, end-to-end framework translating brand objectives into certified, commercially successful clinical formulations.
Define clinical objectives: whether adapting our pre-tested, hypersensitivity-safe stock formulas or engineering a bespoke active matrix (e.g., Palmitamide MEA, Oat Beta-Glucan, Dual Ceramides) matched to target unit cost margins and regional compliance lists.
Iterative sample synthesis within 3 to 7 business days. We provide testing units for dermatological touch, non-irritation feedback, packaging compatibility checks, and centrifuge thermal acceleration tests (48°C / 5°C cycles).
Selection of inert packaging materials: fluorinated airless pumps, medical-grade EVOH barrier soft tubes, or opaque vacuum bottles that protect oxygen-sensitive actives and maintain unpreserved formula stability without plasticizer leaching.
Emulsification in sealed vacuum homogenizers followed by cleanroom filling lines. Rigorous in-process analytical chemistry verifies viscosity, pH (stabilized at physiological 5.2 - 5.8), microbial plate count (<10 CFU/g), and active ingredient assay.
Final issuance of Batch Certificate of Analysis (COA), heavy metal screening reports, full bill of lading, and multi-modal freight coordination (FCL sea freight, air express, or cross-border rail) directly to global regional fulfillment centers.
Essential guidance for pharmaceutical distributors, clinical skincare entrepreneurs, and beauty brand executives.
Integrate certified face, eye, and barrier care products manufactured in our Guangzhou facilities into your private label catalog.
